Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
FREDUN.BOthis companyFredun Pharmaceuticals Limited	₹1,518.80	25.02×	2.94×	1.29×	10.87×	-205.7%	26.6%	13.1%	5.2%	11.7%	10.9%	0.5%	0.87×	1.94×	2.12×	1.68×	0.0%	3	—	2	C
AMBALALSA.BOAmbalal Sarabhai Enterprises Limited	₹35.63	10.46×	1.18×	0.92×	20.11×	-8.8%	23.1%	3.9%	8.8%	11.2%	3.5%	3.9%	0.36×	4.28×	1.91×	1.27×	0.0%	3	—	2	C+
BAFNAPH.NSBafna Pharmaceuticals Limited	₹472.80	23.31×	2.69×	1.72×	14.21×	-102.8%	13.4%	6.6%	7.4%	11.5%	7.2%	-5.1%	0.39×	1.71×	2.7×	1.57×	0.0%	5	—	1	C-
GUJTHEM.NSGujarat Themis Biosyn Limited	₹379.65	53.14×	8.62×	14.96×	33.86×	-93.5%	46.4%	37.8%	28.2%	16.2%	10.3%	-5.2%	0.56×	2.04×	21.23×	1.12×	0.3%	—	—	1	D+
JENBURPH.BOJenburkt Pharmaceuticals Limited	₹959.75	12.14×	2.14×	2.5×	8.36×	76.8%	49.4%	24.1%	20.6%	17.6%	14.9%	3.9%	0.01×	-0.06×	87.95×	4.11×	1.9%	2	—	3	B
KIMIABL.BOKimia Biosciences Ltd.	₹30.08	14.36×	6.02×	0.93×	9.9×	58.3%	24.6%	9.0%	6.5%	41.9%	16.9%	-1.8%	1.96×	2.42×	2.95×	1.04×	0.0%	3	—	2	B-
Peer median	—	14.36×	2.69×	1.72×	14.21×	-8.8%	24.6%	9.0%	8.8%	16.2%	10.3%	-1.8%	0.39×	2.04×	2.95×	1.27×	0.0%	3	—	2	—